Monitoring how your body reacts during the initial phase can help guide discussions with your healthcare provider about adjustments
Looking in the mirror, I suddenly had all of these wrinkles and fine lines that I never had before, she said
Pfizer's Phase 2b results, presented at the American Diabetes Association meeting in 2023, showed that danuglipron produced dose-dependent weight loss and HbA1c reductions in patients with type 2 diabetes, though with significant gastrointestinal tolerability challenges at higher doses
It is a dual agonist of GLP-1 and GIP receptors to help regulate blood sugar levels and reduce appetite to improve glycemic control and support weight loss in patients with chronic conditions
Some gut bacteria synthesize vitamin K, which affects blood clotting
Standard maintenance: - Type I-II: 0.5 mg twice per week - Type III-IV: 0.5 mg once per week - Type V-VI: 0.5 mg every 2-3 weeks Alternative approach: Some users prefer a single larger weekly dose (1.0 mg once per week instead of 0.5 mg twice per week)